Danaher raises 2026 EPS outlook after Q2 revenue rises 5.5% to $6.3 billion
Second-quarter net earnings climbed 60% to $870 million as the company cited stronger Life Sciences performance and earlier-than-expected completion of the Masimo acquisition.